SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-022028
Filing Date
2021-09-03
Accepted
2021-09-03 16:38:10
Documents
12
Period of Report
2021-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 29432
  Complete submission text file 0001493152-21-022028.txt   202351

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mymd-20210901.xsd EX-101.SCH 3012
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mymd-20210901_lab.xml EX-101.LAB 34239
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mymd-20210901_pre.xml EX-101.PRE 22350
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3722
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 211237046
SIC: 2835 In Vitro & In Vivo Diagnostic Substances